Universe Pharmaceuticals Inc (UPC) USD11.25

Sell:$2.71Buy:$3.00Price increased$0.02 (0.74%)

Prices delayed by at least 15 minutes
Sell:$2.71
Buy:$3.00
Change:Price increased$0.02 (0.74%)
Prices delayed by at least 15 minutes
Sell:$2.71
Buy:$3.00
Change:Price increased$0.02 (0.74%)
Prices delayed by at least 15 minutes

Company Information

About this company

Universe Pharmaceuticals Inc is a holding company primarily engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine drugs (TCMDs) products targeting the elderly. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The Company is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.

Key people

Gang Lai
Chairman of the Board, Chief Executive Officer
Lin Yang
Chief Financial Officer, Director
Baochang Liu
Chief Operating Officer
Jiawen Pang
Independent Director
H. David Sherman
Independent Director
Ding Zheng
Independent Director
Click to see more

Key facts

  • Shares in issue
    559,871.00
  • EPIC
    UPC
  • ISIN
    KYG9442G1385
  • Location
    China
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $1.49m
  • Employees
    216
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.